[文献资料]参 考 文 献

Phase Ⅱ study of telatinib（T）in combination with capecitabine（X）and cisplatin（P）as first-line treatment in patients（pts）with advanced cancer of the stomach（G）or gastro-esophageal junction（GEJ）.Analysis of biomarker expression（ki67，EGFR，HER2，ERK，NF-κ B，and ......